Natixis »

Perspective Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2026-06-30 $22k 6.3k 3.41

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors (TSLA)
Spdr Series Trust St Str P500etf (SPYM)
Energy Transfer Com Ut Ltd Ptn (ET)
Broadcom (AVGO)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)

View all positions for Natixis

Top funds holding Perspective Therapeutics

BlackRock
TCG Crossover Management
Commodore Capital
Avidity Partners Management
Millennium Management
Vanguard Capital Management
Affinity Asset Advisors
Citadel Advisors
Spruce Street Capital
Balyasny Asset Management
State Street Corporation
Morgan Stanley
Geode Capital Management
Nantahala Capital Management
Goldman Sachs Group

View all funds holding Perspective Therapeutics